Cargando…

Prospective, observational practice survey of applied skin care and management of cetuximab-related skin reactions: PROSKIN study

PURPOSE: The study aimed to investigate strategies to prevent and treat cetuximab-induced skin reactions and their perceived effectiveness in patients with metastatic colorectal cancer (mCRC) and recurrent/metastatic squamous cell cancer of the head and neck (SCCHN). METHODS: This open-label, prospe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rothschild, Sacha I., Betticher, Daniel, Zenhäusern, Reinhard, Anchisi, Sandro, von Moos, Roger, Pless, Miklos, Moosmann, Peter, Popescu, Razvan A., Calderoni, Antonello, Dressler, Marco, Rauch, Daniel, Pederiva, Stefanie, Woelky, Regina, Papet, Claudia, Bühler, Vera, Borner, Markus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6768912/ https://www.ncbi.nlm.nih.gov/pubmed/31444619 http://dx.doi.org/10.1007/s00280-019-03927-x

Ejemplares similares

EGFR Exon-Level Biomarkers of the Response to Bevacizumab/Erlotinib in Non-Small Cell Lung Cancer
por: Baty, Florent, et al.
Publicado: (2013)

Cetuximab in Refractory Skin Cancer Treatment
por: Kalapurakal, Sini J, et al.
Publicado: (2012)

Cetuximab-induced skin exanthema: prophylactic and reactive skin therapy are equally effective
por: Wehler, Thomas C., et al.
Publicado: (2013)

Preoperative chemotherapy and radiotherapy concomitant to cetuximab in resectable stage IIIB NSCLC: a multicentre phase 2 trial (SAKK 16/08)
por: Curioni-Fontecedro, Alessandra, et al.
Publicado: (2019)

Erratum to: Cetuximab-induced skin exanthema: prophylactic and reactive skin therapy are equally effective
por: Wehler, Thomas C., et al.
Publicado: (2013)

Severe skin reaction secondary to concomitant radiotherapy plus cetuximab
por: Berger, Bernhard, et al.
Publicado: (2008)

Prospective practice survey of management of cetuximab-related skin reactions
por: Lugtenberg, R. T., et al.
Publicado: (2020)

Two Cases of Cerebral Sinus Venous Thrombosis Following Chemotherapy for Non-Seminomatous Germ Cell Tumor
por: Papet, C., et al.
Publicado: (2011)

Tomotherapy concomitant with cetuximab, followed by cetuximab as single-agent therapy for unresectable squamous cell carcinoma of the skin: a case report
por: Falivene, Sara, et al.
Publicado: (2014)

Dramatic response of refractory metastatic squamous cell carcinoma of the skin with cetuximab/pembrolizumab
por: Hober, Candice, et al.
Publicado: (2021)

3-weekly or weekly cisplatin concurrently with radiotherapy for patients with squamous cell carcinoma of the head and neck – a multicentre, retrospective analysis
por: Helfenstein, Seth, et al.
Publicado: (2019)

Recurrent squamous cell carcinoma of the skin treated successfully with single agent cetuximab therapy
por: Seber, Selcuk, et al.
Publicado: (2016)

Identification of immune-related mechanisms of cetuximab induced skin toxicity in colorectal cancer patients
por: Park, Jin Hyun, et al.
Publicado: (2022)

Management of cetuximab-induced skin toxicity with the prophylactic use of topical vitamin K1 cream
por: Ocvirk, Janja
Publicado: (2010)

Lack of Cetuximab induced skin toxicity in a previously irradiated field: case report and review of the literature
por: Kanakamedala, Madhava R, et al.
Publicado: (2010)

Radiolabeled F(ab′)(2)-cetuximab for theranostic purposes in colorectal and skin tumor-bearing mice models
por: Bellaye, P.-S., et al.
Publicado: (2018)

Predictive Value of Cetuximab-Induced Skin Toxicity in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NECK
por: Uozumi, Shinya, et al.
Publicado: (2018)

Chimeric Monoclonal Antibody Cetuximab Targeting Epidermal Growth Factor-Receptor in Advanced Non-Melanoma Skin Cancer
por: Wollina, Uwe, et al.
Publicado: (2017)

The DNA-polymorphism rs849142 is associated with skin toxicity induced by targeted anti-EGFR therapy using cetuximab
por: Froelich, Matthias F., et al.
Publicado: (2018)

Genome wide association study to identify predictors for severe skin toxicity in colorectal cancer patients treated with cetuximab
por: Baas, Jara, et al.
Publicado: (2018)

Skin Disorders and Primary Tumor Location as Prognostic Factors in Patients with Metastatic Colorectal Cancer Treated with Cetuximab and Chemotherapy
por: Takada, Shinya, et al.
Publicado: (2018)

The Riddle of Cetuximab-Related Skin Toxicity: (1)H-NMR Sebum Analysis Revealed Dynamic Lipid Alterations Associated with Skin Toxicity Development in Metastatic Colorectal Cancer Patients
por: Saorin, Asia, et al.
Publicado: (2022)

Effectiveness and toxicity of cetuximab with concurrent RT in locally advanced cutaneous squamous cell skin cancer: a case series
por: Chang, Mark, et al.
Publicado: (2023)

Patients' experiences with cancer care in Switzerland: Results of a multicentre cross‐sectional survey
por: Arditi, Chantal, et al.
Publicado: (2022)

Biomarkers of Skin Graft Healing in Venous Leg Ulcers
por: KIRKETERP-MØLLER, Klaus, et al.
Publicado: (2022)

Lenvatinib in Advanced Radioiodine-Refractory Thyroid Cancer - A Retrospective Analysis of the Swiss Lenvatinib Named Patient Program
por: Balmelli, Catharina, et al.
Publicado: (2018)

Hydrogel increases diclofenac skin permeation and absorption
por: Haltner‐Ukomadu, Eleonore, et al.
Publicado: (2019)

Portable Skin Analyzers with Simultaneous Measurements of Transepidermal Water Loss, Skin Conductance and Skin Hardness
por: Sim, Daniel (Jai Kyoung), et al.
Publicado: (2019)

Real-World Evaluation of Quality of Life, Effectiveness, and Safety of Aflibercept Plus FOLFIRI in Patients with Metastatic Colorectal Cancer: The Prospective QoLiTrap Study
por: Hofheinz, Ralf-Dieter, et al.
Publicado: (2022)

The Pharmaceutical Device Prisma(®) Skin Promotes in Vitro Angiogenesis through Endothelial to Mesenchymal Transition during Skin Wound Healing
por: Belvedere, Raffaella, et al.
Publicado: (2017)

Asian expert recommendation on management of skin and mucosal effects of radiation, with or without the addition of cetuximab or chemotherapy, in treatment of head and neck squamous cell carcinoma
por: Zhu, Guopei, et al.
Publicado: (2016)

Skin toxicity evaluation in patients treated with cetuximab for metastatic colorectal cancer: a new tool for more accurate comprehension of quality of life impacts
por: De Tursi, Michele, et al.
Publicado: (2017)

Skin Toxicity as Predictor of Survival in Refractory Patients with RAS Wild-Type Metastatic Colorectal Cancer Treated with Cetuximab and Avelumab (CAVE) as Rechallenge Strategy
por: Ciardiello, Davide, et al.
Publicado: (2021)

Quality of Life in Patients With Severe Skin Reactions in Course of First-Generation Epidermal Growth Factor Receptor Inhibitors Monoclonal Antibodies (Our Experience With Cetuximab)
por: De Luca, Rossella, et al.
Publicado: (2021)

Completion and publication of clinical trials in a cooperative group: a cohort study of trials of the Swiss Group for Clinical Cancer Research (SAKK)
por: Hayoz, Stefanie, et al.
Publicado: (2023)

Automated Skin Lesion Classification on Ultrasound Images
por: Marosán-Vilimszky , Péter, et al.
Publicado: (2021)

Irritated Skin Is Not Sensitive Skin
por: Misery, Laurent
Publicado: (2021)

Sitcoms’ scintillating skin surveyors()
por: Vatanchi, Marjon, et al.
Publicado: (2019)

Case report: Abrikossoff's tumor of the facial skin
por: Ardeleanu, Valeriu, et al.
Publicado: (2023)

Skin Microbiome, Metabolome and Skin Phenome, from the Perspectives of Skin as an Ecosystem
por: Chen, Huizhen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fbak904s9vr32es46mo7sp39vu